NCT05740722View on ClinicalTrials.gov

Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

August 1, 2027

Study Completion Date

December 30, 2027

Conditions
Multiple SclerosisProgressive Multiple Sclerosis
Interventions
DIETARY_SUPPLEMENT

Nicotinamid riboside

500 mg x 2 po

DIETARY_SUPPLEMENT

Placebo

Placebo tablets

Trial Locations (1)

5019

RECRUITING

Haukeland University Hospital, Bergen

All Listed Sponsors
lead

Haukeland University Hospital

OTHER